Company Filing History:
Years Active: 2005
Title: Francisco Rabaneda Gimenez: Innovator in Virus-Inactivated Human Gammaglobulin G Production
Introduction
Francisco Rabaneda Gimenez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biopharmaceuticals, particularly in the production of virus-inactivated human gammaglobulin G. His innovative approach has implications for improving the safety and efficacy of immunoglobulin therapies.
Latest Patents
Francisco holds a patent for a "Process for the production of virus-inactivated human gammaglobulin G." This patent outlines a method where gammaglobulin is extracted from a fraction isolated by fractionation with ethanol in the presence of a carbohydrate. The process includes reducing contaminants with PEG, applying the solution to an anionic resin exchange column, and obtaining an effluent that undergoes further purification steps. The method emphasizes viral inactivation through pasteurization and solvent/detergent treatment, ensuring the final product is safe for use.
Career Highlights
Francisco Rabaneda Gimenez is associated with Probitas Pharma S.A., where he continues to advance his research and development efforts. His work is pivotal in enhancing the quality of therapeutic products derived from human plasma. His innovative techniques have the potential to set new standards in the biopharmaceutical industry.
Collaborations
He collaborates with esteemed colleagues such as Pere Ristol Debart and Ma Teresa Lopez Hernandez. Their combined expertise contributes to the ongoing success of their projects and the advancement of biopharmaceutical innovations.
Conclusion
Francisco Rabaneda Gimenez is a key figure in the field of biopharmaceuticals, with a focus on improving the safety of human gammaglobulin G production. His contributions through innovative patents and collaborations highlight the importance of research in developing effective medical therapies.